| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCB4
|
ATP-binding cassette, sub-family B (MDR/TAP), member 4
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ACHE
|
acetylcholinesterase (Yt blood group)
|
|
ACKR3
|
atypical chemokine receptor 3
|
|
ACR
|
acrosin
|
|
ACTB
|
actin, beta
|
|
ACVRL1
|
activin A receptor type II-like 1
|
|
ADAM12
|
ADAM metallopeptidase domain 12
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADAM23
|
ADAM metallopeptidase domain 23
|
|
ADH1B
|
alcohol dehydrogenase 1B (class I), beta polypeptide
|
|
ADH1C
|
alcohol dehydrogenase 1C (class I), gamma polypeptide
|
|
ADH7
|
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGRP
|
agouti related neuropeptide
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AHSA1
|
AHA1, activator of heat shock 90kDa protein ATPase homolog 1 (yeast)
|
|
AIMP2
|
aminoacyl tRNA synthetase complex-interacting multifunctional protein 2
|
|
AKR1A1
|
aldo-keto reductase family 1, member A1 (aldehyde reductase)
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALB
|
albumin
|
|
ALCAM
|
activated leukocyte cell adhesion molecule
|
|
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1
|
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
|
ALKBH1
|
alkB, alkylation repair homolog 1 (E. coli)
|
|
ALOX15B
|
arachidonate 15-lipoxygenase, type B
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
ANGPTL4
|
angiopoietin-like 4
|
|
ANKRD36B
|
ankyrin repeat domain 36B
|
|
ANO1
|
anoctamin 1, calcium activated chloride channel
|
|
ANXA1
|
annexin A1
|
|
ANXA2
|
annexin A2
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
APRT
|
adenine phosphoribosyltransferase
|
|
AR
|
androgen receptor
|
|
AREG
|
amphiregulin
|
|
ARF6
|
ADP-ribosylation factor 6
|
|
ARHGAP24
|
Rho GTPase activating protein 24
|
|
ARHGEF5
|
Rho guanine nucleotide exchange factor (GEF) 5
|
|
ARHGEF7
|
Rho guanine nucleotide exchange factor (GEF) 7
|
|
ARID3B
|
AT rich interactive domain 3B (BRIGHT-like)
|
|
ARMC9
|
armadillo repeat containing 9
|
|
ARTN
|
artemin
|
|
ASAH1
|
N-acylsphingosine amidohydrolase (acid ceramidase) 1
|
|
ASAP1
|
ArfGAP with SH3 domain, ankyrin repeat and PH domain 1
|
|
ATF2
|
activating transcription factor 2
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP7B
|
ATPase, Cu++ transporting, beta polypeptide
|
|
AURKA
|
aurora kinase A
|
|
AURKB
|
aurora kinase B
|
|
AVP
|
arginine vasopressin
|
|
AXIN2
|
axin 2
|
|
AXL
|
AXL receptor tyrosine kinase
|
|
BAP1
|
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)
|
|
BAX
|
BCL2-associated X protein
|
|
BBC3
|
BCL2 binding component 3
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BIRC2
|
baculoviral IAP repeat containing 2
|
|
BIRC3
|
baculoviral IAP repeat containing 3
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BSG
|
basigin (Ok blood group)
|
|
BST2
|
bone marrow stromal cell antigen 2
|
|
C1GALT1
|
core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1
|
|
CA9
|
carbonic anhydrase IX
|
|
CALCR
|
calcitonin receptor
|
|
CALR
|
calreticulin
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CBFA2T2
|
core-binding factor, runt domain, alpha subunit 2; translocated to, 2
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCN2
|
cellular communication network factor 2
|
|
CCND1
|
cyclin D1
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CD151
|
CD151 molecule (Raph blood group)
|
|
CD24
|
CD24 molecule
|
|
CD247
|
CD247 molecule
|
|
CD274
|
CD274 molecule
|
|
CD34
|
CD34 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD82
|
CD82 molecule
|
|
CDC73
|
cell division cycle 73
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast)
|
|
CDH19
|
cadherin 19, type 2
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK2AP1
|
cyclin-dependent kinase 2 associated protein 1
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN3
|
cyclin-dependent kinase inhibitor 3
|
|
CEACAM6
|
carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen)
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHRNA3
|
cholinergic receptor, nicotinic, alpha 3 (neuronal)
|
|
CHRNA5
|
cholinergic receptor, nicotinic, alpha 5 (neuronal)
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CIB1
|
calcium and integrin binding 1 (calmyrin)
|
|
CIP2A
|
cellular inhibitor of PP2A
|
|
CISD2
|
CDGSH iron sulfur domain 2
|
|
CISH
|
cytokine inducible SH2-containing protein
|
|
CKAP4
|
cytoskeleton-associated protein 4
|
|
CKMT1A
|
creatine kinase, mitochondrial 1A
|
|
CKMT1B
|
creatine kinase, mitochondrial 1B
|
|
CLOCK
|
clock circadian regulator
|
|
CNFN
|
cornifelin
|
|
CNP
|
2',3'-cyclic nucleotide 3' phosphodiesterase
|
|
COASY
|
CoA synthase
|
|
COL11A2
|
collagen, type XI, alpha 2
|
|
COL18A1
|
collagen, type XVIII, alpha 1
|
|
COL1A2
|
collagen, type I, alpha 2
|
|
COMMD3-BMI1
|
COMMD3-BMI1 readthrough
|
|
COPS5
|
COP9 signalosome subunit 5
|
|
COX2
|
|
|
COX5A
|
cytochrome c oxidase subunit Va
|
|
COX8A
|
cytochrome c oxidase subunit VIIIA (ubiquitous)
|
|
CPOX
|
coproporphyrinogen oxidase
|
|
CPVL
|
carboxypeptidase, vitellogenic-like
|
|
CREBBP
|
CREB binding protein
|
|
CRK
|
v-crk avian sarcoma virus CT10 oncogene homolog
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
|
CSF3R
|
colony stimulating factor 3 receptor (granulocyte)
|
|
CSMD1
|
CUB and Sushi multiple domains 1
|
|
CSMD2
|
CUB and Sushi multiple domains 2
|
|
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide
|
|
CTCF
|
CCCTC-binding factor (zinc finger protein)
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTSB
|
cathepsin B
|
|
CTTN
|
cortactin
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL14
|
chemokine (C-X-C motif) ligand 14
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYGB
|
cytoglobin
|
|
CYLD
|
cylindromatosis (turban tumor syndrome)
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP2A13
|
cytochrome P450, family 2, subfamily A, polypeptide 13
|
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP2D7
|
cytochrome P450, family 2, subfamily D, polypeptide 7 (gene/pseudogene)
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
CYP2R1
|
cytochrome P450, family 2, subfamily R, polypeptide 1
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DCDC2
|
doublecortin domain containing 2
|
|
DCLK1
|
doublecortin-like kinase 1
|
|
DCTN6
|
dynactin 6
|
|
DDIT3
|
DNA-damage-inducible transcript 3
|
|
DDR1
|
discoidin domain receptor tyrosine kinase 1
|
|
DEFB103A
|
defensin, beta 103A
|
|
DEFB103B
|
defensin, beta 103B
|
|
DEK
|
DEK proto-oncogene
|
|
DHFR
|
dihydrofolate reductase
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DNAJB7
|
DnaJ (Hsp40) homolog, subfamily B, member 7
|
|
DNASE1L1
|
deoxyribonuclease I-like 1
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DOK1
|
docking protein 1, 62kDa (downstream of tyrosine kinase 1)
|
|
DPYD
|
dihydropyrimidine dehydrogenase
|
|
DSG1
|
desmoglein 1
|
|
DSG3
|
desmoglein 3
|
|
DSPP
|
dentin sialophosphoprotein
|
|
E2F1
|
E2F transcription factor 1
|
|
ECE1
|
endothelin converting enzyme 1
|
|
EDNRB
|
endothelin receptor type B
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGR1
|
early growth response 1
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1
|
|
EIF6
|
eukaryotic translation initiation factor 6
|
|
ELAVL2
|
ELAV like neuron-specific RNA binding protein 2
|
|
ELK3
|
ELK3, ETS-domain protein (SRF accessory protein 2)
|
|
ENO1
|
enolase 1, (alpha)
|
|
ENTPD1
|
ectonucleoside triphosphate diphosphohydrolase 1
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPHA2
|
EPH receptor A2
|
|
EPHA3
|
EPH receptor A3
|
|
EPHB1
|
EPH receptor B1
|
|
EPHB2
|
EPH receptor B2
|
|
EPHX1
|
epoxide hydrolase 1, microsomal (xenobiotic)
|
|
EPO
|
erythropoietin
|
|
EPS8
|
epidermal growth factor receptor pathway substrate 8
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERCC3
|
excision repair cross-complementation group 3
|
|
ERCC5
|
excision repair cross-complementation group 5
|
|
ERCC6
|
excision repair cross-complementation group 6
|
|
ESM1
|
endothelial cell-specific molecule 1
|
|
ESS2
|
ess-2 splicing factor homolog
|
|
EXO1
|
exonuclease 1
|
|
EXTL3
|
exostosin-like glycosyltransferase 3
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F2RL3
|
coagulation factor II (thrombin) receptor-like 3
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
|
FANCD2
|
Fanconi anemia, complementation group D2
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FAT1
|
FAT atypical cadherin 1
|
|
FCGR1A
|
Fc fragment of IgG, high affinity Ia, receptor (CD64)
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FGF3
|
fibroblast growth factor 3
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
|
FHIT
|
fragile histidine triad
|
|
FJX1
|
four jointed box 1 (Drosophila)
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOSB
|
FBJ murine osteosarcoma viral oncogene homolog B
|
|
FOXH1
|
forkhead box H1
|
|
FOXO3
|
forkhead box O3
|
|
FOXP1
|
forkhead box P1
|
|
G3BP1
|
GTPase activating protein (SH3 domain) binding protein 1
|
|
GABPA
|
GA binding protein transcription factor, alpha subunit 60kDa
|
|
GAL
|
galanin/GMAP prepropeptide
|
|
GALC
|
galactosylceramidase
|
|
GALNS
|
galactosamine (N-acetyl)-6-sulfatase
|
|
GALR1
|
galanin receptor 1
|
|
GALR2
|
galanin receptor 2
|
|
GCLC
|
glutamate-cysteine ligase, catalytic subunit
|
|
GDF15
|
growth differentiation factor 15
|
|
GDNF
|
glial cell derived neurotrophic factor
|
|
GGT1
|
gamma-glutamyltransferase 1
|
|
GGTLC3
|
gamma-glutamyltransferase light chain 3
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GLB1
|
galactosidase, beta 1
|
|
GNG7
|
guanine nucleotide binding protein (G protein), gamma 7
|
|
GOLIM4
|
golgi integral membrane protein 4
|
|
GPR4
|
G protein-coupled receptor 4
|
|
GPX1
|
glutathione peroxidase 1
|
|
GPX3
|
glutathione peroxidase 3
|
|
GPX4
|
glutathione peroxidase 4
|
|
GRAP2
|
GRB2-related adaptor protein 2
|
|
GRN
|
granulin
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTA2
|
glutathione S-transferase alpha 2
|
|
GSTK1
|
glutathione S-transferase kappa 1
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTM2
|
glutathione S-transferase mu 2 (muscle)
|
|
GSTM3
|
glutathione S-transferase mu 3 (brain)
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GUSB
|
glucuronidase, beta
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
|
HAVCR1
|
hepatitis A virus cellular receptor 1
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
|
HDAC4
|
histone deacetylase 4
|
|
HDAC9
|
histone deacetylase 9
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HK2
|
hexokinase 2
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DRB4
|
major histocompatibility complex, class II, DR beta 4
|
|
HLTF
|
helicase-like transcription factor
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HOOK2
|
hook microtubule-tethering protein 2
|
|
HOPX
|
HOP homeobox
|
|
HOXD10
|
homeobox D10
|
|
HOXD11
|
homeobox D11
|
|
HP
|
haptoglobin
|
|
HPGDS
|
hematopoietic prostaglandin D synthase
|
|
HPSE
|
heparanase
|
|
HPSE2
|
heparanase 2 (inactive)
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HSP90B1
|
heat shock protein 90kDa beta (Grp94), member 1
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HSPB2
|
heat shock 27kDa protein 2
|
|
HSPB3
|
heat shock 27kDa protein 3
|
|
HSPD1
|
heat shock 60kDa protein 1 (chaperonin)
|
|
IFI27
|
interferon, alpha-inducible protein 27
|
|
IFNA2
|
interferon, alpha 2
|
|
IFNG
|
interferon, gamma
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2
|
|
IGF2R
|
insulin-like growth factor 2 receptor
|
|
IGFBP5
|
insulin-like growth factor binding protein 5
|
|
IGFBP7
|
insulin-like growth factor binding protein 7
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IL10
|
interleukin 10
|
|
IL13
|
interleukin 13
|
|
IL13RA2
|
interleukin 13 receptor, alpha 2
|
|
IL17A
|
interleukin 17A
|
|
IL18
|
interleukin 18
|
|
IL1B
|
interleukin 1, beta
|
|
IL2
|
interleukin 2
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL4
|
interleukin 4
|
|
IL4R
|
interleukin 4 receptor
|
|
IL6
|
interleukin 6
|
|
ING1
|
inhibitor of growth family, member 1
|
|
ING3
|
inhibitor of growth family, member 3
|
|
ING4
|
inhibitor of growth family, member 4
|
|
ING5
|
inhibitor of growth family, member 5
|
|
INSR
|
insulin receptor
|
|
INSRR
|
insulin receptor-related receptor
|
|
IQGAP1
|
IQ motif containing GTPase activating protein 1
|
|
IQSEC1
|
IQ motif and Sec7 domain 1
|
|
IRAK1
|
interleukin-1 receptor-associated kinase 1
|
|
IRS1
|
insulin receptor substrate 1
|
|
ISG20
|
interferon stimulated exonuclease gene 20kDa
|
|
ITGA3
|
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)
|
|
ITGA6
|
integrin, alpha 6
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
JAG1
|
jagged 1
|
|
JUN
|
jun proto-oncogene
|
|
JUNB
|
jun B proto-oncogene
|
|
JUND
|
jun D proto-oncogene
|
|
KCNA5
|
potassium channel, voltage gated shaker related subfamily A, member 5
|
|
KCNH1
|
potassium channel, voltage gated eag related subfamily H, member 1
|
|
KDM5B
|
lysine (K)-specific demethylase 5B
|
|
KDR
|
kinase insert domain receptor
|
|
KEAP1
|
kelch-like ECH-associated protein 1
|
|
KIF22
|
kinesin family member 22
|
|
KIF2A
|
kinesin heavy chain member 2A
|
|
KISS1
|
KiSS-1 metastasis-suppressor
|
|
KLK2
|
kallikrein-related peptidase 2
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KMT2C
|
lysine (K)-specific methyltransferase 2C
|
|
KNG1
|
kininogen 1
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT17
|
keratin 17, type I
|
|
KRT19
|
keratin 19, type I
|
|
KRT20
|
keratin 20, type I
|
|
LAMC2
|
laminin, gamma 2
|
|
LAT
|
linker for activation of T cells
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LCN2
|
lipocalin 2
|
|
LDHA
|
lactate dehydrogenase A
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1
|
|
LIN28A
|
lin-28 homolog A (C. elegans)
|
|
LIN28B
|
lin-28 homolog B (C. elegans)
|
|
LONP1
|
lon peptidase 1, mitochondrial
|
|
LOX
|
lysyl oxidase
|
|
LRIG1
|
leucine-rich repeats and immunoglobulin-like domains 1
|
|
LTB
|
lymphotoxin beta (TNF superfamily, member 3)
|
|
LTBP3
|
latent transforming growth factor beta binding protein 3
|
|
LTBR
|
lymphotoxin beta receptor (TNFR superfamily, member 3)
|
|
LUC7L3
|
LUC7-like 3 (S. cerevisiae)
|
|
LY6D
|
lymphocyte antigen 6 complex, locus D
|
|
MAGEA1
|
melanoma antigen family A1
|
|
MAGED4
|
melanoma antigen family D4
|
|
MAGED4B
|
melanoma antigen family D4B
|
|
MAL
|
mal, T-cell differentiation protein
|
|
MAP3K13
|
mitogen-activated protein kinase kinase kinase 13
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK12
|
mitogen-activated protein kinase 12
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK6
|
mitogen-activated protein kinase 6
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPKAPK2
|
mitogen-activated protein kinase-activated protein kinase 2
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MCM7
|
minichromosome maintenance complex component 7
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MDM4
|
MDM4, p53 regulator
|
|
MELK
|
maternal embryonic leucine zipper kinase
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MFAP1
|
microfibrillar-associated protein 1
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MGST1
|
microsomal glutathione S-transferase 1
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MLC1
|
megalencephalic leukoencephalopathy with subcortical cysts 1
|
|
MLH1
|
mutL homolog 1
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP10
|
matrix metallopeptidase 10
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP17
|
matrix metallopeptidase 17 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP8
|
matrix metallopeptidase 8
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MOK
|
MOK protein kinase
|
|
MRC1
|
mannose receptor, C type 1
|
|
MRE11
|
MRE11 homolog, double strand break repair nuclease
|
|
MSH2
|
mutS homolog 2
|
|
MSH6
|
mutS homolog 6
|
|
MT-ND4
|
NADH dehydrogenase, subunit 4 (complex I)
|
|
MTA3
|
metastasis associated 1 family, member 3
|
|
MTDH
|
metadherin
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTMR11
|
myotubularin related protein 11
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUL1
|
mitochondrial E3 ubiquitin protein ligase 1
|
|
MUTYH
|
mutY homolog
|
|
MYBBP1A
|
MYB binding protein (P160) 1a
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCBPAP
|
MYCBP associated protein
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
MYL2
|
myosin, light chain 2, regulatory, cardiac, slow
|
|
MYL9
|
myosin, light chain 9, regulatory
|
|
MYOF
|
myoferlin
|
|
NANS
|
N-acetylneuraminic acid synthase
|
|
NAT1
|
N-acetyltransferase 1 (arylamine N-acetyltransferase)
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NBN
|
nibrin
|
|
NCOA1
|
nuclear receptor coactivator 1
|
|
NDUFA13
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13
|
|
NEDD8
|
neural precursor cell expressed, developmentally down-regulated 8
|
|
NEFL
|
neurofilament, light polypeptide
|
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NHS
|
Nance-Horan syndrome (congenital cataracts and dental anomalies)
|
|
NLRP2
|
NLR family, pyrin domain containing 2
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
|
NOD1
|
nucleotide-binding oligomerization domain containing 1
|
|
NOL4
|
nucleolar protein 4
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOTCH1
|
notch 1
|
|
NPC1
|
Niemann-Pick disease, type C1
|
|
NPEPPS
|
aminopeptidase puromycin sensitive
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NR1H2
|
nuclear receptor subfamily 1, group H, member 2
|
|
NSD3
|
nuclear receptor binding SET domain protein 3
|
|
NT5E
|
5'-nucleotidase, ecto (CD73)
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NUAK1
|
NUAK family, SNF1-like kinase, 1
|
|
OBP2A
|
odorant binding protein 2A
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OPN1LW
|
opsin 1 (cone pigments), long-wave-sensitive
|
|
OR10A4
|
olfactory receptor, family 10, subfamily A, member 4
|
|
P2RX1
|
purinergic receptor P2X, ligand gated ion channel, 1
|
|
P2RX2
|
purinergic receptor P2X, ligand gated ion channel, 2
|
|
P2RX3
|
purinergic receptor P2X, ligand gated ion channel, 3
|
|
P2RX4
|
purinergic receptor P2X, ligand gated ion channel, 4
|
|
P2RX5
|
purinergic receptor P2X, ligand gated ion channel, 5
|
|
P2RX6
|
purinergic receptor P2X, ligand gated ion channel, 6
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
P2RY1
|
purinergic receptor P2Y, G-protein coupled, 1
|
|
P2RY2
|
purinergic receptor P2Y, G-protein coupled, 2
|
|
PAEP
|
progestagen-associated endometrial protein
|
|
PAG1
|
phosphoprotein membrane anchor with glycosphingolipid microdomains 1
|
|
PAIP2
|
poly(A) binding protein interacting protein 2
|
|
PAK2
|
p21 protein (Cdc42/Rac)-activated kinase 2
|
|
PALB2
|
partner and localizer of BRCA2
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PAWR
|
PRKC, apoptosis, WT1, regulator
|
|
PAX5
|
paired box 5
|
|
PCBP4
|
poly(rC) binding protein 4
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PCP2
|
Purkinje cell protein 2
|
|
PDCD1
|
programmed cell death 1
|
|
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor)
|
|
PDE5A
|
phosphodiesterase 5A, cGMP-specific
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PDK2
|
pyruvate dehydrogenase kinase, isozyme 2
|
|
PDLIM7
|
PDZ and LIM domain 7 (enigma)
|
|
PDPN
|
podoplanin
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PER1
|
period circadian clock 1
|
|
PFN2
|
profilin 2
|
|
PHEX
|
phosphate regulating endopeptidase homolog, X-linked
|
|
PHF20
|
PHD finger protein 20
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PIK3R2
|
phosphoinositide-3-kinase, regulatory subunit 2 (beta)
|
|
PIM1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
|
PIWIL1
|
piwi-like RNA-mediated gene silencing 1
|
|
PIWIL4
|
piwi-like RNA-mediated gene silencing 4
|
|
PKD2
|
polycystic kidney disease 2 (autosomal dominant)
|
|
PKM
|
pyruvate kinase, muscle
|
|
PKN2
|
protein kinase N2
|
|
PLAG1
|
pleiomorphic adenoma gene 1
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLK3
|
polo-like kinase 3
|
|
POLDIP2
|
polymerase (DNA-directed), delta interacting protein 2
|
|
POMC
|
proopiomelanocortin
|
|
PON1
|
paraoxonase 1
|
|
POSTN
|
periostin, osteoblast specific factor
|
|
POU2F1
|
POU class 2 homeobox 1
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPIG
|
peptidylprolyl isomerase G (cyclophilin G)
|
|
PPP1R12C
|
protein phosphatase 1, regulatory subunit 12C
|
|
PPP1R13B
|
protein phosphatase 1, regulatory subunit 13B
|
|
PPP1R1A
|
protein phosphatase 1, regulatory (inhibitor) subunit 1A
|
|
PPP1R2P9
|
protein phosphatase 1, regulatory (inhibitor) subunit 2 pseudogene 9
|
|
PPP1R3B
|
protein phosphatase 1, regulatory subunit 3B
|
|
PPP1R3C
|
protein phosphatase 1, regulatory subunit 3C
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
|
PRMT1
|
protein arginine methyltransferase 1
|
|
PRMT5
|
protein arginine methyltransferase 5
|
|
PROS1
|
protein S (alpha)
|
|
PRXL2A
|
peroxiredoxin like 2A
|
|
PSAT1
|
phosphoserine aminotransferase 1
|
|
PSMA1
|
proteasome (prosome, macropain) subunit, alpha type, 1
|
|
PSMD9
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 9
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
|
PTGES
|
prostaglandin E synthase
|
|
PTGIS
|
prostaglandin I2 (prostacyclin) synthase
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTHLH
|
parathyroid hormone-like hormone
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN13
|
protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase)
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
PTPRT
|
protein tyrosine phosphatase, receptor type, T
|
|
PTTG1IP
|
pituitary tumor-transforming 1 interacting protein
|
|
PTX3
|
pentraxin 3, long
|
|
RAB25
|
RAB25, member RAS oncogene family
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAD17
|
RAD17 homolog (S. pombe)
|
|
RAD50
|
RAD50 homolog (S. cerevisiae)
|
|
RAD51
|
RAD51 recombinase
|
|
RAD51C
|
RAD51 paralog C
|
|
RAD52
|
RAD52 homolog (S. cerevisiae)
|
|
RARB
|
retinoic acid receptor, beta
|
|
RARS1
|
arginyl-tRNA synthetase 1
|
|
RASA2
|
RAS p21 protein activator 2
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RASSF2
|
Ras association (RalGDS/AF-6) domain family member 2
|
|
RB1
|
retinoblastoma 1
|
|
RBL1
|
retinoblastoma-like 1
|
|
RBP4
|
retinol binding protein 4, plasma
|
|
RBX1
|
ring-box 1, E3 ubiquitin protein ligase
|
|
RECQL5
|
RecQ protein-like 5
|
|
REG3A
|
regenerating islet-derived 3 alpha
|
|
REG3G
|
regenerating islet-derived 3 gamma
|
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog
|
|
RELB
|
v-rel avian reticuloendotheliosis viral oncogene homolog B
|
|
RFC1
|
replication factor C (activator 1) 1, 145kDa
|
|
RHBDF1
|
rhomboid 5 homolog 1 (Drosophila)
|
|
RHOBTB1
|
Rho-related BTB domain containing 1
|
|
RITA1
|
RBPJ interacting and tubulin associated 1
|
|
RNF19A
|
ring finger protein 19A, RBR E3 ubiquitin protein ligase
|
|
ROBO1
|
roundabout, axon guidance receptor, homolog 1 (Drosophila)
|
|
RORA
|
RAR-related orphan receptor A
|
|
ROS1
|
ROS proto-oncogene 1 , receptor tyrosine kinase
|
|
RPE65
|
retinal pigment epithelium-specific protein 65kDa
|
|
RPS27A
|
ribosomal protein S27a
|
|
RPS9
|
ribosomal protein S9
|
|
RRM1
|
ribonucleotide reductase M1
|
|
RRM2B
|
ribonucleotide reductase M2 B (TP53 inducible)
|
|
RUNX2
|
runt-related transcription factor 2
|
|
RUNX3
|
runt-related transcription factor 3
|
|
RYR2
|
ryanodine receptor 2 (cardiac)
|
|
S100A2
|
S100 calcium binding protein A2
|
|
S100A4
|
S100 calcium binding protein A4
|
|
S100A7
|
S100 calcium binding protein A7
|
|
SCD
|
stearoyl-CoA desaturase (delta-9-desaturase)
|
|
SCO2
|
SCO2 cytochrome c oxidase assembly protein
|
|
SDC1
|
syndecan 1
|
|
SDCCAG8
|
serologically defined colon cancer antigen 8
|
|
SEC14L2
|
SEC14-like 2 (S. cerevisiae)
|
|
SEC62
|
SEC62 homolog (S. cerevisiae)
|
|
SELENBP1
|
selenium binding protein 1
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
|
SEMA4D
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINB2
|
serpin peptidase inhibitor, clade B (ovalbumin), member 2
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SESN1
|
sestrin 1
|
|
SESN2
|
sestrin 2
|
|
SETDB1
|
SET domain, bifurcated 1
|
|
SF3B1
|
splicing factor 3b, subunit 1, 155kDa
|
|
SH3BP4
|
SH3-domain binding protein 4
|
|
SHMT1
|
serine hydroxymethyltransferase 1 (soluble)
|
|
SHQ1
|
SHQ1, H/ACA ribonucleoprotein assembly factor
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLC10A1
|
solute carrier family 10 (sodium/bile acid cotransporter), member 1
|
|
SLC12A9
|
solute carrier family 12, member 9
|
|
SLC23A2
|
solute carrier family 23 (ascorbic acid transporter), member 2
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC2A3
|
solute carrier family 2 (facilitated glucose transporter), member 3
|
|
SLC43A2
|
solute carrier family 43 (amino acid system L transporter), member 2
|
|
SLC5A5
|
solute carrier family 5 (sodium/iodide cotransporter), member 5
|
|
SLC6A2
|
solute carrier family 6 (neurotransmitter transporter), member 2
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC6A8
|
solute carrier family 6 (neurotransmitter transporter), member 8
|
|
SLC7A5
|
solute carrier family 7 (amino acid transporter light chain, L system), member 5
|
|
SLCO6A1
|
solute carrier organic anion transporter family, member 6A1
|
|
SLPI
|
secretory leukocyte peptidase inhibitor
|
|
SMAD4
|
SMAD family member 4
|
|
SMARCA2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2
|
|
SMN1
|
survival of motor neuron 1, telomeric
|
|
SMN2
|
survival of motor neuron 2, centromeric
|
|
SMO
|
smoothened, frizzled class receptor
|
|
SMUG1
|
single-strand-selective monofunctional uracil-DNA glycosylase 1
|
|
SNX8
|
sorting nexin 8
|
|
SOAT1
|
sterol O-acyltransferase 1
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOX11
|
SRY (sex determining region Y)-box 11
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin)
|
|
SPHK1
|
sphingosine kinase 1
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SPRR1A
|
small proline-rich protein 1A
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SSSCA1
|
Sjogren syndrome/scleroderma autoantigen 1
|
|
ST13
|
suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein)
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STIM1
|
stromal interaction molecule 1
|
|
STK11
|
serine/threonine kinase 11
|
|
STUB1
|
STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase
|
|
SULT1A1
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1
|
|
TACSTD2
|
tumor-associated calcium signal transducer 2
|
|
TAS2R13
|
taste receptor, type 2, member 13
|
|
TAS2R5
|
taste receptor, type 2, member 5
|
|
TAX1BP1
|
Tax1 (human T-cell leukemia virus type I) binding protein 1
|
|
TBC1D9
|
TBC1 domain family, member 9 (with GRAM domain)
|
|
TBPL1
|
TBP-like 1
|
|
TCF12
|
transcription factor 12
|
|
TCF21
|
transcription factor 21
|
|
TCHP
|
trichoplein, keratin filament binding
|
|
TDP2
|
tyrosyl-DNA phosphodiesterase 2
|
|
TERF2
|
telomeric repeat binding factor 2
|
|
TERT
|
telomerase reverse transcriptase
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TET3
|
tet methylcytosine dioxygenase 3
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TFRC
|
transferrin receptor
|
|
TGFA
|
transforming growth factor, alpha
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TGM3
|
transglutaminase 3
|
|
TICAM2
|
toll-like receptor adaptor molecule 2
|
|
TIMELESS
|
timeless circadian clock
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TIMP3
|
TIMP metallopeptidase inhibitor 3
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR8
|
toll-like receptor 8
|
|
TMC8
|
transmembrane channel-like 8
|
|
TMED7
|
transmembrane emp24 protein transport domain containing 7
|
|
TMED7-TICAM2
|
TMED7-TICAM2 readthrough
|
|
TMEM97
|
transmembrane protein 97
|
|
TNC
|
tenascin C
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP2
|
tumor necrosis factor, alpha-induced protein 2
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
|
TNFRSF10D
|
tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF4
|
tumor necrosis factor receptor superfamily, member 4
|
|
TNFRSF9
|
tumor necrosis factor receptor superfamily, member 9
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TPI1
|
triosephosphate isomerase 1
|
|
TRIM63
|
tripartite motif containing 63, E3 ubiquitin protein ligase
|
|
TRIP13
|
thyroid hormone receptor interactor 13
|
|
TRPC4
|
transient receptor potential cation channel, subfamily C, member 4
|
|
TRPM7
|
transient receptor potential cation channel, subfamily M, member 7
|
|
TSPAN31
|
tetraspanin 31
|
|
TTR
|
transthyretin
|
|
TUBE1
|
tubulin, epsilon 1
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
TXN
|
thioredoxin
|
|
TYMP
|
thymidine phosphorylase
|
|
TYMS
|
thymidylate synthetase
|
|
UBC
|
ubiquitin C
|
|
UBE2Q2
|
ubiquitin-conjugating enzyme E2Q family member 2
|
|
UGCG
|
UDP-glucose ceramide glucosyltransferase
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
UGT1A6
|
UDP glucuronosyltransferase 1 family, polypeptide A6
|
|
UGT1A7
|
UDP glucuronosyltransferase 1 family, polypeptide A7
|
|
UGT2B17
|
UDP glucuronosyltransferase 2 family, polypeptide B17
|
|
UROD
|
uroporphyrinogen decarboxylase
|
|
USP9X
|
ubiquitin specific peptidase 9, X-linked
|
|
UVRAG
|
UV radiation resistance associated
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VHLL
|
von Hippel-Lindau tumor suppressor-like
|
|
WEE1
|
WEE1 G2 checkpoint kinase
|
|
WIF1
|
WNT inhibitory factor 1
|
|
WRAP53
|
WD repeat containing, antisense to TP53
|
|
WT1
|
Wilms tumor 1
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XPC
|
xeroderma pigmentosum, complementation group C
|
|
XPO1
|
exportin 1
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
XRCC2
|
X-ray repair complementing defective repair in Chinese hamster cells 2
|
|
XRCC3
|
X-ray repair complementing defective repair in Chinese hamster cells 3
|
|
XRCC5
|
X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining)
|
|
YAP1
|
Yes-associated protein 1
|
|
ZBTB32
|
zinc finger and BTB domain containing 32
|
|
ZEB2
|
zinc finger E-box binding homeobox 2
|
|
ZFP36
|
ZFP36 ring finger protein
|
|
ZNF331
|
zinc finger protein 331
|
|
ZNF395
|
zinc finger protein 395
|
|
ZNF645
|
zinc finger protein 645
|
|
ZNF654
|
zinc finger protein 654
|
|
ZNF703
|
zinc finger protein 703
|
